OSLO—Norway will not resume use of the COVID-19 vaccine made by AstraZeneca, and a decision on whether to include Johnson & Johnson shots in its mass inoculation scheme remains on hold, Prime Minister Erna Solberg said on Wednesday. A government-appointed commission had recommended that both vaccines be excluded from Norway’s program due to the risk of rare but harmful side effects. Authorities on March 11 suspended the AstraZeneca rollout after a small number of inoculated people, some of whom later died, were hospitalized for a combination of blood clots, bleeding, and a low platelet count. A study in Denmark and Norway found slightly increased rates of blood clots among people who have had a first dose of AstraZeneca’s vaccine, including in the brain, compared with expected rates in the general population. The Johnson & Johnson (J&J) vaccine has not been used in Norway so far despite European Medicines Agency (EMA) …